General Announcement for PLC

12/08/2021

OTHERS Surat Setuju Terima for the Supply and Distribution of Covid-19 Vaccine Coronavac Suspension for Injection between Pharmaniaga Lifescience Sdn Bhd, a wholly-owned subsidiary of Pharmaniaga Berhad and Government of Malaysia.

PHARMANIAGA BERHAD

Type Announcement
Subject OTHERS
Description 
Surat Setuju Terima for the Supply and Distribution of Covid-19 Vaccine Coronavac Suspension for Injection between Pharmaniaga Lifescience Sdn Bhd, a wholly-owned subsidiary of Pharmaniaga Berhad and Government of Malaysia.

The Board of Directors of Pharmaniaga Berhad (“the Company”) wishes to announce that Pharmaniaga Lifescience Sdn Bhd, a wholly-owned subsidiary of the Company has on 11 August 2021 signed the Surat Setuju Terima (Tambahan) Perolehan Pembekalan Covid-19 Coronavac Suspension (“Covid 19 Vaccine”) with the Government of Malaysia for the combined purchase of an additional six million (6,000,000) doses of Fill & Finished and Imported Finished Product of Covid-19 Vaccine.

 

Please refer to the attachment for details of the announcement.

 

This announcement is dated 12 August 2021.


Please refer attachment below.


Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 12 Aug 2021
Category General Announcement for PLC
Reference Number GA1-12082021-00014


Related Announcements for PHARMA
Date Title
30/03/2022 OTHERS Memorandum of Understanding between Pharmaniaga Manufacturing Berhad and Prime Medical Store L.L.C
25/02/2022 OTHERS Memorandum of Understanding between Pharmaniaga Research Centre Sdn Bhd and Bio-Innova Co. Ltd
25/02/2022 OTHERS Memorandum of Understanding between Pharmaniaga Lifescience Sdn Bhd & Bionet Asia Co. Ltd.
11/01/2022 OTHERS UPDATE ON THE CONCESSION AGREEMENT DATED 16 MARCH 2011 BETWEEN THE GOVERNMENT OF MALAYSIA (REPRESENTED BY THE MINISTRY OF HEALTH OF MALAYSIA) AND PHARMANIAGA LOGISTICS SDN BHD (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad's Main Market Listing Requirement)
30/12/2021 OTHERS UPDATE ON THE CONCESSION AGREEMENT DATED 16 MARCH 2011 BETWEEN THE GOVERNMENT OF MALAYSIA (REPRESENTED BY THE MINISTRY OF HEALTH OF MALAYSIA) AND PHARMANIAGA LOGISTICS SDN BHD (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad's Main Market Listing Requirement)
01/11/2021 MEMORANDUM OF UNDERSTANDING Pharmaniaga Berhad ("Pharmaniaga" or "the Company") Memorandum of Understanding between Pharmaniaga Research Centre Sdn Bhd, a wholly-owned subsidiary of the Company and National Institutes of Biotechnology Malaysia.
07/07/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") BONUS ISSUE
06/07/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") BONUS ISSUE
19/05/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") PROPOSED BONUS ISSUE
10/05/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR ''COMPANY'') PROPOSED BONUS ISSUE